Financials
- Market Capitalization 1.33 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-8.74
주가매출액비율
941.13
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 2208 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 4.14 USD | -7.80% | -8.81% | -17.20% | -17.03% | 1.35 B USD | ||
| 2214 | ANAB AnaptysBio, Inc. - Common Stock | 46.04 USD | +0.20% | -6.82% | -15.63% | +30.80% | 1.34 B USD | ||
| 2252 | DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.26 USD | -1.04% | -4.81% | +1.06% | +264.71% | 1.26 B USD | ||
| 2257 | GHRS GH Research PLC - Ordinary Shares | 20.02 USD | -5.16% | -9.94% | -26.40% | +41.38% | 1.24 B USD |